InSilico Medicine Cayman TopCo (HKG:3696)

Hong Kong · Delayed Price · Currency is HKD

64.30

-1.10 (-1.68%)

At close: May 8, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biotechnology	51.18M	30.15M
Biotechnology Growth	69.77%	-
Total	51.18M	30.15M
Total Growth	69.77%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	45.91M	9.37M
United States Growth	389.72%	-
Chinese Mainland	3.45M	9.24M
Chinese Mainland Growth	-62.67%	-
Hong Kong	23.00K	10.01M
Hong Kong Growth	-99.77%	-
Japan	438.00K	207.00K
Japan Growth	111.59%	-
United Kingdom	46.00K	59.00K
United Kingdom Growth	-22.03%	-
Denmark	270.00K	-
United Arab Emirates	6.00K	-
Korea	53.00K	2.00K
Korea Growth	2550.00%	-
Germany	93.00K	332.00K
Germany Growth	-71.99%	-
Switzerland	655.00K	766.00K
Switzerland Growth	-14.49%	-
Taiwan	34.00K	82.00K
Taiwan Growth	-58.54%	-
Others	209.00K	80.00K
Others Growth	161.25%	-
Total	51.18M	30.15M
Total Growth	69.77%	-

Source: S&P Global Market Intelligence.